Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors

The ex vivo sensitivity of pediatric leukemia cells to the proteasome inhibitor bortezomib was compared to 3 next generation proteasome inhibitors: the epoxyketone-based irreversible proteasome inhibitors carfilzomib, its orally bio-available analog ONX 0912, and the immunoproteasome inhibitor ONX 0...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Niewerth, Denise, Franke, Niels E., Jansen, Gerrit, Assaraf, Yehuda G., van Meerloo, Johan, Kirk, Christopher J., Degenhardt, Jeremiah, Anderl, Janet, Schimmer, Aaron D., Zweegman, Sonja, de Haas, Valerie, Horton, Terzah M., Kaspers, Gertjan J.L., Cloos, Jacqueline
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ferrata Storti Foundation 2013
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3856965/
https://ncbi.nlm.nih.gov/pubmed/24056819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.092411
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak